Cafepharma Today

October 17 2024 - Sage lays off half of R&D team, shakes up C-suite again
Sage lays off half of R&D team, shakes up C-suite again
Sanofi inks $326M radiopharma deal with Orano
Novartis loses latest bid to block generic version of blockbuster heart drug
Kezar to discontinue mid-stage trial for lupus treatment
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
BioSpace
Friday, October 4, 2024 - 9:17am
tags:
Sanofi, Recordati, autoimmune disease, cold agglutinin disease
BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval
Fierce Pharma
Thursday, October 3, 2024 - 10:25pm
tags:
Bristol Myers Squibb, Opdivo, FDA, non-small cell lung cancer
AbbVie cuts 2024 profit forecast citing R&D expenses
Reuters
Thursday, October 3, 2024 - 9:26pm
tags:
AbbVie, R&D
Relay cuts more staff in efforts to save $50M a year
Fierce Biotech
Thursday, October 3, 2024 - 9:25pm
tags:
Relay Therapeutics, precision medicine, layoffs
1 In 4 Physicians Say Prior Authorization Harms Patients. Reform Is Coming
Forbes
Thursday, October 3, 2024 - 8:28pm
tags:
insurance, patients, prior authorizations
Novo Nordisk has mitigation plans to minimize disruption from port strikes
Reuters
Thursday, October 3, 2024 - 11:47am
tags:
Novo Nordisk, logistics, labor strike, Wegovy, Ozempic
Big pharma, biotech relations ‘won't necessarily be symbiotic’ in future AI landscape: S&P
Fierce Biotech
Thursday, October 3, 2024 - 10:57am
tags:
Big Pharma, artificial intelligence, innovation, biotech
FDA grants fast track status for Volastra’s VLS-1488 to treat ovarian cancer
Pharmaceutical Business Review
Thursday, October 3, 2024 - 10:40am
tags:
Volastra Therapeutics, VLS-1488, ovarian cancer, platinum-resistant ovarian cancer
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Clinical Trials Arena
Thursday, October 3, 2024 - 10:37am
tags:
Arcus Biosciences, AstraZeneca, renal cancer, casdatifan, renal cell carcinoma
Septerna files for IPO on strength of preclinical data, vision for expanding GPCR landscape
Fierce Biotech
Thursday, October 3, 2024 - 10:32am
tags:
Septerna, IPOs, hypoparathyroidism
Legend set to open Philadelphia cell therapy R&D site next year
Fierce Biotech
Thursday, October 3, 2024 - 10:12am
tags:
Legene Biotech, cell therapy, R&D, Pennsylvania, Philadelphia
Lilly's weight-loss drug removed from FDA's shortage list
Reuters
Thursday, October 3, 2024 - 10:06am
tags:
Eli Lilly, FDA, drug shortages, Mounjaro
Why a CVS breakup may be hard to execute
Beckers Hospital Review
Thursday, October 3, 2024 - 9:50am
tags:
CVS Health, pharmacies
Chiesi Group launches biotechnology center in Italy, backed by a €400m investment
Biopharma Reporter
Thursday, October 3, 2024 - 9:46am
tags:
The Chiesi Group, Italy, biotech
Google DeepMind and biotech company BioNTech are each developing 'AI lab assistants'
Gigazine
Thursday, October 3, 2024 - 9:42am
tags:
Google DeepMind, BioNTech, artificial intelligence, R&D
Louisiana district court upholds state 340B contract pharmacy law
American Hospital Association
Wednesday, October 2, 2024 - 10:01pm
tags:
legal, Louisiana, 340B, contract pharmacies, AbbVie, AstraZeneca, PhRMA
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Reuters
Wednesday, October 2, 2024 - 9:55pm
tags:
Gilead Sciences, generics, HIV, lenacapavir
EMA concerned about MAA delays, working on solutions
RAPS.org
Wednesday, October 2, 2024 - 9:53pm
tags:
EMA, Europe, drug approvals
J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study
Fierce Pharma
Wednesday, October 2, 2024 - 9:50pm
tags:
JNJ, Erleada, prostate cancer, Astellas, Pfizer, Xtandi
Medicare Issues Updated Rules for Second Round of Drug Negotiations
US News and World Report
Wednesday, October 2, 2024 - 9:49pm
tags:
CMS, drug pricing, Medicare, Inflation Reduction Act

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline
Induced Proximity, in the Lab and in the Clinic
In the Pipeline
If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?
Drug Channels
Half-Full and Half-Empty AI Glasses
In the Pipeline
As MFP Approaches, Transparency Is More Important Than Ever
Drug Channels
Long, Slow Stories
In the Pipeline
Coronavirus Vaccination: Room for Improvement
In the Pipeline
Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond
Drug Channels
The 2024 Chemistry Nobel: Computational Protein Design
In the Pipeline

Latest Jobs

Virtual Lead Generation & Sales Specialist - Pharmaceuticals
Jacksonville, Florida, 32290
Syneos Health/ inVentiv Health Commercial LLC
Neuroscience Account Manager (Psychiatry) - Pensacola, FL
Pensacola, Florida, 32573
Vanda Pharmaceuticals
Structural Heart/ICE Territory Sales Manager, Northwest
Issaquah, Washington, 98027
Siemens Medical Solutions USA, Inc
Sales Executive
Everett, Washington, 98213
Abel Consulting
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Territory Account Manager
Orange, California, 92613
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement, CNS - Charlottesville, VA
Roanoke, Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago W, IL
Chicago, Illinois,
Otsuka
Pharmaceutical Sales Customer Engagement- Corpus Christi, TX
Corpus Christi, Texas,
Otsuka
Hearing Aid Sales Consultant
Barrington, Rhode Island, 02806
Beltone New England
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information